Evaxion Mar 5, 2026 Copy link Evaxion plans to file 2025 annual report later today COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company Business